AU2002309475A1 - Esmolol formulation - Google Patents
Esmolol formulationInfo
- Publication number
- AU2002309475A1 AU2002309475A1 AU2002309475A AU2002309475A AU2002309475A1 AU 2002309475 A1 AU2002309475 A1 AU 2002309475A1 AU 2002309475 A AU2002309475 A AU 2002309475A AU 2002309475 A AU2002309475 A AU 2002309475A AU 2002309475 A1 AU2002309475 A1 AU 2002309475A1
- Authority
- AU
- Australia
- Prior art keywords
- esmolol formulation
- esmolol
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- AQNDDEOPVVGCPG-UHFFFAOYSA-N esmolol Chemical compound COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1 AQNDDEOPVVGCPG-UHFFFAOYSA-N 0.000 title 1
- 229960003745 esmolol Drugs 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/759,547 US6310094B1 (en) | 2001-01-12 | 2001-01-12 | Ready-to-use esmolol solution |
| US09/759,547 | 2001-01-12 | ||
| US10/016,260 | 2001-10-30 | ||
| US10/016,260 US6528540B2 (en) | 2001-01-12 | 2001-10-30 | Esmolol formulation |
| PCT/US2002/000329 WO2002076446A1 (en) | 2001-01-12 | 2002-01-02 | Esmolol formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002309475A1 true AU2002309475A1 (en) | 2003-03-27 |
| AU2002309475B2 AU2002309475B2 (en) | 2006-08-03 |
Family
ID=26688377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002309475A Expired AU2002309475B2 (en) | 2001-01-12 | 2002-01-02 | Esmolol formulation |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1368019B2 (en) |
| JP (1) | JP2004519506A (en) |
| CN (1) | CN1298320C (en) |
| AT (1) | ATE341319T1 (en) |
| AU (1) | AU2002309475B2 (en) |
| BR (1) | BR0203517A (en) |
| CA (1) | CA2410446C (en) |
| CZ (1) | CZ304290B6 (en) |
| DE (1) | DE60215129T3 (en) |
| DK (1) | DK1368019T4 (en) |
| ES (1) | ES2272720T5 (en) |
| HU (1) | HUP0204520A3 (en) |
| IL (1) | IL151359A (en) |
| MX (1) | MXPA03006229A (en) |
| PL (1) | PL216192B1 (en) |
| RU (1) | RU2286774C2 (en) |
| SI (1) | SI1368019T2 (en) |
| SK (1) | SK288113B6 (en) |
| TR (1) | TR200202557T1 (en) |
| TW (1) | TWI277414B (en) |
| WO (1) | WO2002076446A1 (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6310094B1 (en) * | 2001-01-12 | 2001-10-30 | Baxter International Inc. | Ready-to-use esmolol solution |
| EP1417962A1 (en) | 2002-11-06 | 2004-05-12 | AOP Orphan Pharmaceuticals AG | Method for the manufacture of a medicament comprising esmolol |
| ES2373042T3 (en) * | 2003-10-08 | 2012-01-30 | Mallinckrodt Llc | SOLUTION OF METHYLPHENIDATE AND ASSOCIATED PRODUCTION AND ADMINISTRATION PROCEDURES. |
| CN1303987C (en) * | 2004-11-19 | 2007-03-14 | 陈庆财 | Esmolol Hydrochloride freeze dried powder for injection and its preparation method |
| US20080293814A1 (en) * | 2007-05-22 | 2008-11-27 | Deepak Tiwari | Concentrate esmolol |
| AU2014203121B2 (en) * | 2007-05-22 | 2016-04-21 | Baxter Healthcare Sa | Concentrate esmolol |
| US8722736B2 (en) * | 2007-05-22 | 2014-05-13 | Baxter International Inc. | Multi-dose concentrate esmolol with benzyl alcohol |
| US8426467B2 (en) * | 2007-05-22 | 2013-04-23 | Baxter International Inc. | Colored esmolol concentrate |
| US20100311738A1 (en) * | 2007-12-21 | 2010-12-09 | Aop Orphan Pharmaceuticals Ag | Pharmaceutical Composition For The Parenteral Administration Of Ultrashort-Effective Beta-Adrenoreceptor Antagonists |
| US8741953B2 (en) * | 2009-09-22 | 2014-06-03 | Vlife Sciences Technologies Pvt. Ltd. | Topical formulation for diabetic foot ulcers |
| ES2363964B1 (en) | 2009-11-20 | 2012-08-22 | Gp Pharm, S.A. | CAPSULES OF PHARMACEUTICAL ACTIVE PRINCIPLES AND ESTERS OF POLYINSATURATED FATTY ACIDS. |
| AU2012211318C1 (en) * | 2011-01-27 | 2016-08-04 | Baxter Healthcare S.A. | Methods of treating tachycardia and/or controlling heart rate while minimizing and/or controlling hypotension |
| CA2825716A1 (en) | 2011-01-27 | 2012-08-02 | Baxter Healthcare S.A. | Use of (s) -esmolol for controlling venous irritation associated with the treatment of a cardiac disorder |
| NZ701429A (en) | 2012-05-10 | 2016-04-29 | Aop Orphan Pharmaceuticals Ag | Parenteral esmolol formulation |
| US8835505B1 (en) | 2013-03-15 | 2014-09-16 | Welgrace Research Group | Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container |
| CN104473869A (en) * | 2014-11-20 | 2015-04-01 | 北京京科泰来科技有限公司 | Esmolol fat emulsion and preparation method thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4857552A (en) * | 1988-06-08 | 1989-08-15 | E. I. Du Pont De Nemours And Co. | Stable pharmaceutical composition |
| CN1074763C (en) * | 1997-11-13 | 2001-11-14 | 山东省医药工业研究所 | Process for synthesizing and refining esmolol hydrochloride |
-
2001
- 2001-12-14 TW TW090131012A patent/TWI277414B/en not_active IP Right Cessation
-
2002
- 2002-01-02 TR TR2002/02557T patent/TR200202557T1/en unknown
- 2002-01-02 SK SK1278-2002A patent/SK288113B6/en not_active IP Right Cessation
- 2002-01-02 WO PCT/US2002/000329 patent/WO2002076446A1/en active IP Right Grant
- 2002-01-02 HU HU0204520A patent/HUP0204520A3/en not_active Application Discontinuation
- 2002-01-02 EP EP02736473A patent/EP1368019B2/en not_active Expired - Lifetime
- 2002-01-02 CA CA002410446A patent/CA2410446C/en not_active Expired - Lifetime
- 2002-01-02 MX MXPA03006229A patent/MXPA03006229A/en active IP Right Grant
- 2002-01-02 PL PL357387A patent/PL216192B1/en unknown
- 2002-01-02 SI SI200230444T patent/SI1368019T2/en unknown
- 2002-01-02 IL IL151359A patent/IL151359A/en active IP Right Grant
- 2002-01-02 BR BR0203517-0A patent/BR0203517A/en not_active Application Discontinuation
- 2002-01-02 DE DE60215129T patent/DE60215129T3/en not_active Expired - Lifetime
- 2002-01-02 JP JP2002574961A patent/JP2004519506A/en not_active Withdrawn
- 2002-01-02 RU RU2002132189/15A patent/RU2286774C2/en active
- 2002-01-02 CZ CZ2002-3825A patent/CZ304290B6/en not_active IP Right Cessation
- 2002-01-02 ES ES02736473T patent/ES2272720T5/en not_active Expired - Lifetime
- 2002-01-02 AT AT02736473T patent/ATE341319T1/en active
- 2002-01-02 AU AU2002309475A patent/AU2002309475B2/en not_active Expired
- 2002-01-02 DK DK02736473.6T patent/DK1368019T4/en active
- 2002-01-02 CN CNB028000676A patent/CN1298320C/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002313565A1 (en) | Putter-heads | |
| AU2002257582A1 (en) | Pharmaceutical formulation | |
| AU2002317568A1 (en) | Technical field | |
| AU2002338436A1 (en) | Hcg formulation | |
| AU2002309475A1 (en) | Esmolol formulation | |
| AU2002319532A1 (en) | Feeding-bottles | |
| AU2002355542A1 (en) | Protonic formulation | |
| AU2002313943A1 (en) | Electromobile | |
| AU2002226571A1 (en) | Biligands | |
| AU2001100406A4 (en) | DriverSMS | |
| AU2002313073A1 (en) | Phytocystatin | |
| AU2002329433A1 (en) | Formulation | |
| AU2002343300A1 (en) | Novel formulation | |
| AU2002257925A1 (en) | Numberplates | |
| AU2002300836A1 (en) | Solid Formulation | |
| AUPR454901A0 (en) | Nutrient formulation | |
| AU2001100522A4 (en) | e-Trans | |
| AU2002100746A4 (en) | Adrail | |
| AU2001100214A4 (en) | Dolly-trolley | |
| AU2001100338A4 (en) | Sunglove | |
| AU2001100532A4 (en) | FonePark | |
| AU2001236040A1 (en) | Skin-improving composition set | |
| AU2002254110A1 (en) | Enteral formulation | |
| AU2002339723A1 (en) | Pharmaceutical composition comprising chito-oligomers | |
| AU2001286181A1 (en) | Pharmaceutical composition comprising (-)-secoisolariciresinol |